AssetMark’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AssetMark's VCYT Position: Q3 2026 in Review
AssetMark increased its Veracyte (VCYT) stake by 16% in Q3 2026, buying an estimated $20.2K and bringing the position to 3,013 shares worth $139K. The position accounts for ﹤0.01% of the portfolio, ranked #1561.
AssetMark first reported a position in VCYT in Q4 2019 and has held it in 28 quarters since. The position peaked at $454K in Q2 2024. 305 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.
- AssetMark held 3,013 shares of Veracyte worth $139K as of Q3 2026.
- AssetMark bought 419 Veracyte shares in Q3 2026, an estimated $20.2K.
- Veracyte made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #1561 holding.
- AssetMark first reported a position in Veracyte in Q4 2019 and has held it in 28 quarters since.
- AssetMark's Veracyte position peaked at $454K in Q2 2024.
- 305 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.